UAB Novo Nordisk Pharma is an enterprise in Lithuania, with the main office in Vilnius. It operates in the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers industry. The company was established on May 12, 2005. It currently has a total number of 23 (2025) employees. From the latest financial highlights, UAB Novo Nordisk Pharma reported a net sales revenue increase of 31.2% in 2024. In, 2024, the company’s net profit margin increased by 0.08%.

Headquarters
J. Jasinskio g. 16B
Vilnius; Vilnius county; Postal Code: LT-03163

Contact Details: Purchase the UAB Novo Nordisk Pharma report to view the information.

Website: http://www.novonordisk.lt

Basic Information

Total Employees:

Purchase the UAB Novo Nordisk Pharma report to view the information.

Registered Capital:

Purchase the UAB Novo Nordisk Pharma report to view the information.

Financial Auditors:

Purchase the UAB Novo Nordisk Pharma report to view the information.

Incorporation Date:

May 12, 2005

Key Executives

Purchase this report to view the information.

Member of the Management Board

Ownership Details

Purchase this report to view the information.

Company Performance

Financial values in the chart are available after UAB Novo Nordisk Pharma report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.

Net sales revenue

31.2%▲

Total operating revenue

31.2%▲

Net Profit (Loss) for the Period

34.24%▲

Total Equity

55.04%▲

Net Profit Margin

0.08%▲

Return on Equity (ROE)

-5.5%▼

UAB Novo Nordisk Pharma (Lithuania)